Julia Marie Eastland, CEO & President at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 8,755 shares at $2.43 ($21K) on 2026-02-06, disclosed to the SEC on 2026-02-10.
Open-market sale of $21k ZNTL by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.43 | 7,866 | $19K | 90.0% |
| 2 | $2.39 | 889 | $2K | 10.0% |
| Total | $2.43 avg | 8,755 | $21K | 100% |